Analyst Ratings for POINT Biopharma Global Inc. (PNT)
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
N/A
Rating Score: 4.2 / 10
Percentile Rank: 42%
Rating Score: 4.2 / 10
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/21/2023 | Brookline Capital Markets | Kemp Dolliver | Downgrade | Hold (Buy) |
12.50 (27.00) |
12.45 (12.50) |
0.4% | Details |
| 10/24/2023 | Piper Sandler | Edward Tenthoff | Downgrade | Neutral (Overweight) |
12.50 (N/A) |
12.95 (12.50) |
-3.47% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||


